3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
3
Recruiting
2
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Carcinoma, Non-Small-Cell Lung
3
Neoplasms by Histologic Type
2
Myeloproliferative Disorders
2
Leukemia, Myeloid
2
Hematologic Diseases
2
Bone Marrow Diseases
2
Small Cell Lung Carcinoma
1
Piebaldism
1
Malignant Hepatobiliary Neoplasm
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hematologic Neoplasms
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Blast Crisis
1
Adenocarcinoma of Lung
1
Interventions
Cyclophosphamide
59
fludarabine phosphate
56
Peripheral Blood Stem Cell Transplantation
55
Busulfan
42
Cyclosporine
39
Mycophenolic Acid
35
Antilymphocyte Serum
34
Filgrastim
32
Tacrolimus
31
Radiotherapy
31
Imatinib Mesylate
28
Whole-Body Irradiation
25
Methotrexate
24
Methylprednisolone
23
Cord Blood Stem Cell Transplantation
18
sargramostim
16
Etoposide
16
Dasatinib
16
Interferon-alpha
15
Cytarabine
15
Melphalan
14
nilotinib
11
Thiotepa
9
Therapeutics
9
Cyclosporins
9
Flow Cytometry
8
Psychiatric Rehabilitation
7
Polymerase Chain Reaction
6
thymoglobulin
5
merphos
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Myeloid, Chronic-Phase
×
ponatinib
×
Clear all
NCT02467270
2026-03-17
OPTIC
Takeda
Phase 2
Completed
283 enrolled
31 charts